These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Galitzky J; Reverte M; Portillo M; Carpéné C; Lafontan M; Berlan M Am J Physiol; 1993 Mar; 264(3 Pt 1):E403-12. PubMed ID: 8096365 [TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of extracellular signal-regulated kinases 1 and 2 in 3T3-L1 adipocytes by stimulation of beta(3)-adrenoceptor. Mizuno K; Kanda Y; Kuroki Y; Tomiyama K; Watanabe Y Eur J Pharmacol; 1999 Nov; 385(1):63-9. PubMed ID: 10594345 [TBL] [Abstract][Full Text] [Related]
25. Syntheses and beta-adrenoceptor activities of 2-alkylamino-6-hydroxy-5-hydroxymethyl-1,2,3,4-tetrahydro-1-naphthalenols. Sugihara H; Ukawa K; Kuriki H; Nishikawa M; Sanno Y Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):2988-3002. PubMed ID: 23907 [No Abstract] [Full Text] [Related]
26. Effect of a specific tetrahydroisoquinoline on the blood pressure in animals. Siu PM; Vick JA Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):203-8. PubMed ID: 4023409 [TBL] [Abstract][Full Text] [Related]
27. The effect of a beta-adrenergic agonist on behaviors mediated by 5-HT1A and 5-HT1B receptors. Frances H; Simon P Biol Psychiatry; 1986 Sep; 21(11):1075-7. PubMed ID: 2943324 [No Abstract] [Full Text] [Related]
28. The syntheses and beta-adrenoceptor activities of N-substituted 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthalenols. Itoh K; Motohashi M; Kuriki H; Sugihara H; Inatomi N; Nishikawa M; Oka Y Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):2917-28. PubMed ID: 23906 [No Abstract] [Full Text] [Related]
29. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists. Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339 [TBL] [Abstract][Full Text] [Related]
30. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN. Sumners C; De Vries JB; Dijkstra D; Horn AS Eur J Pharmacol; 1981 Apr; 70(4):541-50. PubMed ID: 6113149 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and pharmacological investigations of 1,2,3,4-tetrahydroisoquinoline derivatives. Brzezinska E; Venter D; Glinka R Pharmazie; 1996 Jun; 51(6):397-9. PubMed ID: 8767849 [TBL] [Abstract][Full Text] [Related]
32. Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Daly SA; Waddington JL Neuropharmacology; 1993 May; 32(5):509-10. PubMed ID: 8321432 [TBL] [Abstract][Full Text] [Related]
33. Effect of an original piperazine derivative of tetraline on the adrenergically mediated metabolic responses in cats and rats. Bogoslovova T; Staneva-Stoytcheva D Acta Physiol Pharmacol Bulg; 1988; 14(4):55-64. PubMed ID: 2907712 [TBL] [Abstract][Full Text] [Related]
34. QSAR of N-alkylated 2-aminotetralins as central dopamine receptor stimulating agents. Lien EJ; Nilsson JL Acta Pharm Suec; 1983; 20(4):271-6. PubMed ID: 6637518 [No Abstract] [Full Text] [Related]
35. NN-Dialkyl derivatives of 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene as selective agonists at presynaptic alpha-adrenoceptors in the rat. Hicks PE; Cannon JG J Pharm Pharmacol; 1979 Jul; 31(7):494-6. PubMed ID: 38331 [No Abstract] [Full Text] [Related]
36. 1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonists. Bakshi RK; Hong Q; Olson JT; Ye Z; Sebhat IK; Weinberg DH; MacNeil T; Kalyani RN; Tang R; Martin WJ; Strack A; McGowan E; Tamvakopoulos C; Miller RR; Stearns RA; Tang W; Maclntyre DE; van der Ploeg LH; Patchett AA; Nargund RP Bioorg Med Chem Lett; 2005 Jul; 15(14):3430-3. PubMed ID: 15951175 [TBL] [Abstract][Full Text] [Related]
37. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor. Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716 [TBL] [Abstract][Full Text] [Related]
38. Conformationally defined adrenergic agents. 5. Resolution, absolute configuration, and pharmacological characterization of the enantiomers of 2-(5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthyl)imidazoline: a potent agonist at alpha-adrenoceptors. DeBernardis JF; Kerkman DJ; Arendsen DL; Buckner SA; Kyncl JJ; Hancock AA J Med Chem; 1987 Jun; 30(6):1011-7. PubMed ID: 2884313 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro. He Y; Nikulin VI; Vansal SS; Feller DR; Miller DD J Med Chem; 2000 Feb; 43(4):591-8. PubMed ID: 10691685 [TBL] [Abstract][Full Text] [Related]
40. Noradrenaline modulates oyster hemocyte phagocytosis via a beta-adrenergic receptor-cAMP signaling pathway. Lacoste A; Malham SK; Cueff A; Poulet SA Gen Comp Endocrinol; 2001 Jun; 122(3):252-9. PubMed ID: 11356037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]